Prevention of severe infectious complications after colorectal surgery using oral non-absorbable antimicrobial prophylaxis: results of a multicenter randomized placebo-controlled clinical trial
Tessa Mulder(Utrecht University), Jan Kluytmans(University Medical Center Utrecht), E. van der Vorm(Reinier de Graaf Hospital), Nils van ‘t Veer(Amphia Ziekenhuis), Martine De Vos(Erasmus MC), Erik Bathoorn(University Medical Center Groningen), Jacobien Veenemans(Admiraal De Ruyter Ziekenhuis), Alexandra Brandt(Erasmus University Rotterdam), A.J.L. Weersink(Meander Medisch Centrum), Marc J. M. Bonten(Utrecht University), Anke B. Smits(St. Antonius Ziekenhuis), Bart J. M. Vlaminckx(St. Antonius Ziekenhuis), Anne Marie G. A. de Smet(Altrecht GGZ), Marjolein Kluytmans-van den Bergh(University Medical Center Utrecht), Boudewijn van Etten(University Medical Center Groningen), Stavros Nikolakopoulos(Utrecht University), Daphne Roos(Amsterdam UMC Location University of Amsterdam), Robert de Vos tot Nederveen Cappel(Admiraal De Ruyter Ziekenhuis), Paul M. Verheijen(Meander Medisch Centrum)
Cited by 14
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k